EXTON, Pa., Feb. 2, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2022 financial results before the market opens on Thursday, February 16, 2023, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.
Read more at prnewswire.comProvided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.